4.7 Review

Engineering Genetic Systems for Treating Mitochondrial Diseases

期刊

PHARMACEUTICS
卷 13, 期 6, 页码 -

出版社

MDPI
DOI: 10.3390/pharmaceutics13060810

关键词

mitochondrial disease; gene therapy; mitochondrial DNA; heteroplasmy; mitochondrial gene delivery

资金

  1. National Research Foundation of Korea (NRF) [2016M3A9B6947831, 2020R1A2C2005893]
  2. Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) - Ministry of Agriculture, Food and Rural Affairs (MAFRA) [118094-03]
  3. Technology Development Program - Ministry of SMEs and Startups (MSS, Korea) [S2938432]
  4. Korea Technology & Information Promotion Agency for SMEs (TIPA) [S2938432] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
  5. National Research Foundation of Korea [2016M3A9B6947831, 2020R1A2C2005893] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Mitochondria are intracellular energy generators whose dysfunction can lead to serious diseases. Understanding the molecular mechanisms underlying mitochondrial dysfunction is crucial for treating mitochondrial diseases. This review summarizes the key genetic processes, core genetic components, and genetic methods used to alleviate the adverse effects of mutations on mitochondrial physiology and functions.
Mitochondria are intracellular energy generators involved in various cellular processes. Therefore, mitochondrial dysfunction often leads to multiple serious diseases, including neurodegenerative and cardiovascular diseases. A better understanding of the underlying mitochondrial dysfunctions of the molecular mechanism will provide important hints on how to mitigate the symptoms of mitochondrial diseases and eventually cure them. In this review, we first summarize the key parts of the genetic processes that control the physiology and functions of mitochondria and discuss how alterations of the processes cause mitochondrial diseases. We then list up the relevant core genetic components involved in these processes and explore the mutations of the components that link to the diseases. Lastly, we discuss recent attempts to apply multiple genetic methods to alleviate and further reverse the adverse effects of the core component mutations on the physiology and functions of mitochondria.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据